Repression of androgen-regulated gene expression by dominant negative androgen receptors
详细信息 查看全文
- 作者：Bramlett ; Kelli S. ; Dits ; Natasja F.J. ; Sui ; Xiaomei ; Jorge ; Michael C. ; Zhu ; Xi ; Jenster ; Guido
- 关键词：Steroid receptor ; Histone deacetylase ; Transcription repression ; Transactivation ; Dominant negative mutant ; Steroid hormones ; AR ; androgen receptor ; GR ; glucocorticoid receptor ; LBD ; ligand binding domain ; DBD ; DNA binding domain ; HDAC ; histone deacetylas
- 刊名：Molecular and Cellular Endocrinology
- 出版年：2001
- 出版时间：October 25, 2001
- 年：2001
- 卷：183
- 期：1-2
- 页码：19-28
- 全文大小：380 K
文摘
The androgen receptor (AR) is a ligand-dependent transcription activator responsible for male sexual development. In order to specifically inhibit the AR pathway, dominant negative ARs were constructed by inactivation of the major transactivation domains of the wild type AR and fusing this mutant (AR122) to the Krüppel-associated box (KRAB) repressor domain and/or histone deacetylase (HDAC1). The HDAC1-KRAB-AR122 protein was the most successful dominant negative AR, capable of repressing the wild type AR ninefold when co-expressed at a 1:1 plasmid ratio. A maximal repression of 41-fold was achieved when HDAC1-KRAB-AR122 was cotransfected with the wild type AR at a 4:1 plasmid ratio. HDAC1-KRAB-AR122 repressed transcription in a ligand-dependent manner since it inhibited a constitutively active AR mutant (AR5) only in the presence of agonists. High concentrations of partial agonists such as RU486, cyproterone acetate, and estradiol were also capable of triggering repression by HDAC1-KRAB-AR122. The potent dominant negative AR proteins might prove useful tools to inhibit AR function in vitro and in vivo.